Stephen D. Linehan has been named president and CEO of the imaging services provider Radiologix. Linehan steps in for Mark S. Martin, who has resigned as president and COO. During his 30-year career, Linehan has held executive and board-level positions
Stephen D. Linehan has been named president and CEO of the imaging services provider Radiologix. Linehan steps in for Mark S. Martin, who has resigned as president and COO. During his 30-year career, Linehan has held executive and board-level positions with public and private healthcare companies, as president and CEO of Rotech Healthcare, a provider of home respiratory care and durable medical equipment and services to patients with breathing disorders, and as president of Value Rx, a $1 billion pharmacy benefits management unit of Value Health.
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.